AI Drug Discovery Startup Omabit Closes Seed Round, Got Its Start at AGI House Hackathons
agihouse_org · x · 2026-10-28
AGI House announced that startup Omabit has closed its seed round. Founders Elena Cassidy and Jesse Eaton first met and won hackathons hosted at AGI House, and the community has followed their growth since.
Omabit builds AI tools that help drug developers mine insights from clinical-trial and genomic data, placing it in the early-stage AI-for-pharma space.
More from Companies & People
- Anthropic disclosure: no insurer, or even the whole industry, could cover catastrophic AI risk — wfithian · 2026-10-28
- Dario: Those who called his GPT-2 fears 'pseudoscience' in 2019 now all apply to AI labs — irinarish · 2026-10-28
- After mom's missed cancer diagnosis, founder builds AI agents for patient follow-up — aakashgupta · 2026-10-28
- Kaggle Launches 'Beyond the Leaderboard' Video Series on Winning With Restricted Compute — MeganRisdal · 2026-10-28
- Dyna Robotics aims to put 100 million robots in the world, hiring full-stack talent — JasonMa2020 · 2026-10-28
- From Vietnam soccer kid to Dyna robotics scientist after a breakout training feature — JasonMa2020 · 2026-10-28